Showing 20 of 107 recruiting trials for “acute-leukemia-of-ambiguous-lineage”
RecruitingNCT05290662 ↗
Registry of Patients Having Received oNKord®
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
RecruitingNCT05326919 ↗
The Patient Cohort of the National Center for Precision Medicine in Leukemia
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
👨⚕️ Depei Wu, MD. PhD, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Sep 2021View details ↗
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
👨⚕️ Liangding Hu, M.D., the Fifth Medical Center the PLA General Hospital📍 1 site📅 Started Jul 2021View details ↗
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
👨⚕️ Antonio Curti, Istituto di Ematologia Seràgnoli, Azienda Ospedaliero-Universitaria di Bologna (IRCCS)📍 1 site📅 Started Jan 2021View details ↗
5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
👨⚕️ Benjamin H Tomlinson, Tomlinson, Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center📍 1 site📅 Started Nov 2020View details ↗
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
👨⚕️ Timothy Olson, MD, PhD, Children's Hospital of Philadelphia📍 1 site📅 Started Mar 2019View details ↗
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
👨⚕️ John Perentesis, MD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Dec 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →